Mario Marcondes, MD PhD
About Mario Marcondes, MD PhD
Mario Marcondes, MD PhD, serves as the Vice President Head of Clinical Development at Nektar Therapeutics, bringing over 15 years of expertise in Bone Marrow Transplantation and Cellular Therapies. He has held various leadership roles in clinical development and research at notable organizations, including Gilead Sciences and Fred Hutchinson Cancer Research Center.
Current Role at Nektar Therapeutics
Mario Marcondes serves as the Vice President and Head of Clinical Development at Nektar Therapeutics since 2022. In this role, he is responsible for overseeing the development of clinical programs, including the management of Phase 1/2 program development. His duties encompass planning and executing investigator and Data Monitoring Committee (DMC) meetings, as well as regulatory submissions. He previously held the position of Executive Director of Clinical Development at Nektar Therapeutics from 2019 to 2022.
Previous Experience in Clinical Research
Mario Marcondes has extensive experience in clinical research, having worked at several notable organizations. He served as Associate Director of Clinical Research at Gilead Sciences from 2015 to 2017. Prior to that, he was a Research Member at Fred Hutchinson Cancer Research Center from 2010 to 2012 and completed a Post Doctoral Fellowship there from 2007 to 2010. He also held the position of Assistant Professor at the University of Washington from 2013 to 2015.
Educational Background and Qualifications
Mario Marcondes holds a Doctor of Medicine (MD) degree from Taubate Sao Paulo Medical School, which he completed from 1994 to 2000. He pursued further medical training through a Hematology-Oncology Residency Program at Public Servant Hospital Sao Paulo SP from 2002 to 2004. He also completed an Internal Medicine Residency Program at the same institution from 2000 to 2002. Additionally, he earned a PhD in Pathology/Experimental Pathology from the University of Washington from 2006 to 2010.
Expertise in Clinical Development
Mario Marcondes possesses over 15 years of research and teaching experience in Bone Marrow Transplantation and Cellular Therapies. He has detailed knowledge in combinatorial approaches in Immune-Oncology and post Bone Marrow transplant settings. His responsibilities include ensuring data integrity and interpretation in Phase 1/2/3 trials for both internal and external presentations. He is also the Program Lead for NKTR-255 (IL15) and NKTR-262 (TLR7/8 agonist) in early-stage clinical development.
Professional Affiliations
Mario Marcondes is an active member of several professional organizations, including the American Society of Clinical Oncology and the American Society of Hematology. These affiliations reflect his commitment to staying engaged with the latest advancements in clinical oncology and hematology.